TB screening and prevention in pregnant women with HIV
Part of Immune system & allergy, Infections clinical trials.
This trial tests a TB screening method to help more pregnant women with HIV get preventive treatment. It aims to find and treat hidden TB early, keeping both mom and baby safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with a healthy single baby (confirmed by ultrasound).
- You have HIV that has been diagnosed and confirmed.
- You are not currently being treated for TB and have not been treated for TB in the last 2 years.
- You have not taken any TB-related medication in the past 2 weeks.
- You live within 12 miles of the study site and plan to give birth there.
- You are not showing signs of early or active labor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
This study tests a community-friendly way to deliver TB prevention medicine (called TPT) to people's homes in Kenya. Researchers want to see if bringing screening and treatment to your house—instead of making you go to a clinic—helps more people start and finish TB prevention, which can reduce TB spread in your community.
This study looks at how common tuberculosis is in pregnant and new mothers. It aims to improve TB detection and care for women in Guinea-Bissau.
This trial tests a two-drug HIV treatment (dolutegravir and lamivudine) for people who also have active TB and are taking a standard TB medicine called rifampin. It is designed for those who have not yet started HIV treatment.
This trial checks if the once-daily HIV pill Biktarvy (B/F/TAF) stays safe and works well for women who are newly pregnant (up to 12 weeks). It is for women already taking Biktarvy with a controlled virus load.
This study tests a daily combination of two medicines, rifapentine and isoniazid (called 1HP), to prevent tuberculosis (TB) in children under 13 years old. It includes children who have been exposed to TB or are at high risk, both those living with HIV and those without HIV.
Hear when a new Pregnant HIV Positive Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.